Tretinoin BHT Adduct Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Tretinoin BHT Adduct Impurity

● In Stock

Catalogue No.:VE0022693
CAS No.:N/A
Mol. Formula:C35H50O3
Mol. Weight:518.8 g/mol

Additional information on Tretinoin BHT Adduct Impurity

Parent drug

Tretinoin

IUPAC Name

2, 6-Di-tert-butyl-3-hydroxybenzyl (2E, 4E, 6E, 8E)-3, 7-dimethyl-9-(2, 6, 6-trimethylcyclohex-1-en-1-yl)nona-2, 4, 6, 8-tetraenoate

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(OCC1=C(C(C)(C)C)C=CC(O)=C1C(C)(C)C)/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C

InChI

InChI=1S/C35H50O3/c1-24(17-18-28-26(3)16-13-21-35(28, 10)11)14-12-15-25(2)22-31(37)38-23-27-29(33(4, 5)6)19-20-30(36)32(27)34(7, 8)9/h12, 14-15, 17-20, 22, 36H, 13, 16, 21, 23H2, 1-11H3/b15-12+, 18-17+, 24-14+, 25-22+

Description

The compound Tretinoin BHT Adduct Impurity is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Tretinoin. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url